Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20142
20151
20161
20171
20183
20202
20214
20221
20234
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15
Unknown status9
Active, not recruiting6
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University5
West China Hospital3
Fudan University2
Shandong Cancer Hospital and Institute2
Sir Run Run Shaw Hospital2
Amgen1
Chinese Academy of Medical Sciences1
Chinese University of Hong Kong1
LI XIN-XIANG1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms32
Colonic Neoplasms6
Colorectal Neoplasms6
Carcinoma, Renal Cell1
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Emergence Delirium1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.